Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib.
Rothstein B, Joshipura D, Saraiya A, Abdat R, Ashkar H, Turkowski Y, Sheth V, Huang V, Au SC, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D. Rothstein B, et al. Among authors: rosmarin d. J Am Acad Dermatol. 2017 Jun;76(6):1054-1060.e1. doi: 10.1016/j.jaad.2017.02.049. Epub 2017 Apr 5. J Am Acad Dermatol. 2017. PMID: 28390737
Anti IL-17 flared psoriasis in a patient on secukinumab.
Noell C, McQuade B, Gottlieb A, Rosmarin D. Noell C, et al. Among authors: rosmarin d. Dermatol Ther. 2017 Jul;30(4). doi: 10.1111/dth.12505. Epub 2017 May 26. Dermatol Ther. 2017. PMID: 28547879 No abstract available.
Importance of light in the treatment of vitiligo with JAK-inhibitors.
Joshipura D, Plotnikova N, Goldminz A, Deverapalli S, Turkowski Y, Gottlieb A, Rosmarin D. Joshipura D, et al. Among authors: rosmarin d. J Dermatolog Treat. 2018 Feb;29(1):98-99. doi: 10.1080/09546634.2017.1339013. Epub 2017 Jun 29. J Dermatolog Treat. 2018. PMID: 28581823 No abstract available.
177 results